163 related articles for article (PubMed ID: 32351772)
1. Pseudohypoaldosteronism Type 1 Newborn Patient with a Novel Mutation in
Seyhanli M; Ilhan O; Gumus E; Bor M; Karaca M
J Pediatr Intensive Care; 2020 Jun; 9(2):145-148. PubMed ID: 32351772
[TBL] [Abstract][Full Text] [Related]
2. Novel SCNN1A gene splicing-site mutation causing autosomal recessive pseudohypoaldosteronism type 1 (PHA1) in two Italian patients belonging to the same small town.
Serra G; Antona V; D'Alessandro MM; Maggio MC; Verde V; Corsello G
Ital J Pediatr; 2021 Jun; 47(1):138. PubMed ID: 34134742
[TBL] [Abstract][Full Text] [Related]
3. Systemic Pseudohypoaldosteronism Type 1 due to 3 Novel Mutations in SCNN1Aand SCNN1BGenes.
Cayir A; Demirelli Y; Yildiz D; Kahveci H; Yarali O; Kurnaz E; Vuralli D; Demirbilek H
Horm Res Paediatr; 2019; 91(3):175-185. PubMed ID: 31018202
[TBL] [Abstract][Full Text] [Related]
4. A Unique Genotype of Pseudohypoaldosteronism Type 1b in a Highly Consanguineous Population.
Alzahrani AS; Alswailem M; Abbas BB; Qasem E; Alsagheir A; Al Shidhani A; Al Sinani A; Al Badi M; Al-Maqbali A; Al Shawi M; Albunyan A; Bin Nafisah A; Shi Y
J Endocr Soc; 2021 Aug; 5(8):bvab095. PubMed ID: 34258491
[TBL] [Abstract][Full Text] [Related]
5. A novel splice site mutation of the beta subunit gene of epithelial sodium channel (ENaC) in one Turkish patient with a systemic form of pseudohypoaldosteronism Type 1.
Dogan CS; Erdem D; Mesut P; Merve A; Sema A; Iffet B; Afig B
J Pediatr Endocrinol Metab; 2012; 25(9-10):1035-9. PubMed ID: 23426840
[TBL] [Abstract][Full Text] [Related]
6. High aldosterone and cortisol levels in salt wasting congenital adrenal hyperplasia: a clinical conundrum.
Boddu SK; Madhavan S
J Pediatr Endocrinol Metab; 2017 Nov; 30(12):1327-1331. PubMed ID: 29127765
[TBL] [Abstract][Full Text] [Related]
7. Clinical Management in Systemic Type Pseudohypoaldosteronism Due to
Karacan Küçükali G; Çetinkaya S; Tunç G; Oğuz MM; Çelik N; Akkaş KY; Şenel S; Güleray Lafcı N; Savaş Erdeve Ş
J Clin Res Pediatr Endocrinol; 2021 Nov; 13(4):446-451. PubMed ID: 32840096
[TBL] [Abstract][Full Text] [Related]
8. Pseudohypoaldosteronism in a newborn male with functional polymorphisms in the mineralocorticoid receptor genes.
Jeong HA; Park YK; Jung YS; Nam MH; Nam HK; Lee KH; Rhie YJ
Ann Pediatr Endocrinol Metab; 2015 Dec; 20(4):230-4. PubMed ID: 26817011
[TBL] [Abstract][Full Text] [Related]
9. Salt-Losing Syndrome in a Girl with Type I and II Pseudohypoaldosteronism.
Szmigielska A
Am J Case Rep; 2022 Oct; 23():e937536. PubMed ID: 36303414
[TBL] [Abstract][Full Text] [Related]
10. Systemic Pseudohypoaldosteronism Type 1 Due to a Novel Mutation in SCNN1B Gene: A Case Report.
Joshi K; Verma PK; Barman M
EJIFCC; 2022 Oct; 33(3):268-273. PubMed ID: 36447799
[TBL] [Abstract][Full Text] [Related]
11. Failure to thrive, hyponatremia, and hyperkalemia in a neonate.
Sopfe J; Simmons JH
Pediatr Ann; 2013 May; 42(5):74-9. PubMed ID: 23641881
[TBL] [Abstract][Full Text] [Related]
12. Cross-reactivity of adrenal steroids with aldosterone may prevent the accurate diagnosis of congenital adrenal hyperplasia.
Tuhan HU; Catli G; Anik A; Onay H; Dundar B; Bober E; Abaci A
J Pediatr Endocrinol Metab; 2015 May; 28(5-6):701-4. PubMed ID: 25503463
[TBL] [Abstract][Full Text] [Related]
13. Novel mutations in the SCNN1A gene causing Pseudohypoaldosteronism type 1.
Wang J; Yu T; Yin L; Li J; Yu L; Shen Y; Yu Y; Shen Y; Fu Q
PLoS One; 2013; 8(6):e65676. PubMed ID: 23762408
[TBL] [Abstract][Full Text] [Related]
14. Systemic pseudohypoaldosteronism-1 with episodic dyslipidemia in a Sudanese child.
Abdalla A; Alhassan MA; Tawfeeg R; Sanad A; Tawamie H; Abdullah M
Endocrinol Diabetes Metab Case Rep; 2021 Jun; 2021():. PubMed ID: 34165441
[TBL] [Abstract][Full Text] [Related]
15. A case of severe systemic type 1 pseudohypoaldosteronism with 10 years of evolution.
Coelho Almeida A; Bastos Gomes M; Martins SA; Marques OP; Gomes MM; Antunes AM
J Pediatr Endocrinol Metab; 2022 Nov; 35(11):1448-1452. PubMed ID: 35918792
[TBL] [Abstract][Full Text] [Related]
16. Pseudohypoaldosteronism type 1 due to a novel mutation in the mineralocorticoid receptor gene.
Loomba-Albrecht LA; Nagel M; Bremer AA
Horm Res Paediatr; 2010; 73(6):482-6. PubMed ID: 20453518
[TBL] [Abstract][Full Text] [Related]
17. [Neonatal systemic pseudohypoaldosteronism type I].
Cao XC; Chen YY; Zhang K; Zhang XJ; Yang L; Li ZH
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jul; 25(7):774-778. PubMed ID: 37529962
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathogenesis of renal pseudohypoaldosteronism type 1.
Riepe FG
Expert Rev Endocrinol Metab; 2007 May; 2(3):407-419. PubMed ID: 30743803
[TBL] [Abstract][Full Text] [Related]
19. Rare Cause of Hyperkalemia in the Newborn Period: Report of Two Cases of Pseudohypoaldosteronism Type 1.
Manipriya R; Umamaheswari B; Prakash A; Binu N
Indian J Nephrol; 2018; 28(1):69-72. PubMed ID: 29515305
[TBL] [Abstract][Full Text] [Related]
20. A case of systemic pseudohypoaldosteronism with a novel mutation in the SCNN1A gene.
Silva N; Costa M; Silva A; Sá C; Martins S; Antunes A; Marques O; Castedo S; Pereira A
Endocrinol Nutr; 2013 Jan; 60(1):33-6. PubMed ID: 23031435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
